
Last updated: about 17 hours ago
FDA Turmoil: A Crisis for Biotech Recovery and Investor Confidence
Internal challenges at the FDA are jeopardizing biotech stocks and investor confidence. Key companies like Amgen, Gilead, and Regeneron face delays that could impact their futures.
